Head of Investor Relations
Insight Molecular Diagnostics Inc. (IMDX)Equibles does not estimate personal net worth.
Get an email with a short summary when Insight Molecular Diagnostics Inc. publishes a filing, an earnings call transcript or a press release.
Get IMDX alertsGabby is recorded as Head of Investor Relations at Insight Molecular Diagnostics Inc. (IMDX). Gabby has spoken on 3 earnings calls across 1 company, most recently for Insight Molecular Diagnostics Inc. on May 13, 2026. Insight Molecular Diagnostics Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Insight Molecular Diagnostics Inc. includes Joshua Riggs (CEO and Board Member), Ronald Andrews (CEO), Andrew Arno (Chairman and Board Member) and 7 others.
“I know this has come up previously, but how are you balancing the desire of accounts to participate in the registry study versus getting commercial wins? And I know you're going to make money on the registry study, but how are you thinking about that?”
“Welcome everyone and thank you for joining us to discuss Insight Molecular Diagnostics fourth quarter 2025 results.”
“Welcome, everyone, and thank you for joining us to discuss OncoSight's first quarter 2025 results. If you have not seen today's shareholder letter, please visit OncoSight's investor relations page at investors.oncosight.com. Today's prepared remarks build upon the information already shared in this robust letter.”
Diagnostics & Research · Healthcare
Head of Investor Relations
